関連する実験動画
Updated: Sep 30, 2026

08:42
Myo-mechanical Analysis of Isolated Skeletal Muscle
Published on: February 22, 2011
ディアゼパムは,筋細胞融合と筋肉特異のタンパク質合成の発現を阻害する
まとめ
ディアゼパムは,高用量で細胞融合を防ぐことで,鶏の胚における筋肉細胞の分化を妨げます. 低用量はミオシン合成を阻害し,融合は筋肉特異のタンパク質の蓄積を必要としないことを示しています.
科学分野:
- 筋肉細胞生物学について
- 発達生物学 発達生物学とは
- 薬理学 薬理学とは
背景:
- 筋肉細胞の分化は,ミオブラスト融合と筋肉特有のタンパク質の合成を含む複雑なプロセスです.
- ミオゲネシスを調節する分子メカニズムを理解することは,再生医療と筋肉疾患の理解に不可欠です.
研究 の 目的:
- 鶏の胚ミオブラストの微分化にダイアゼパムの効果を in vitro で調査する.
- ディアゼパムがミオブラスト融合と筋肉特異のタンパク質合成に影響を与える特定のメカニズムを決定する.
主な方法:
- 鶏の胚ミオブラストの初等培養が確立されました.
- ミオブラストは,様々な濃度のディアゼパムで治療された.
- 細胞融合,ミオチューブ形成,ミオシン重鎖合成を評価した.
主要な成果:
- ディアゼパムは,投与量に依存した方法で正常な筋肉細胞の分化を止めました.
- 高濃度のダイアゼパムは,多核ミオチューブへのミオブラスト融合を逆転的に阻害した.
- 低濃度のディアゼパムは細胞融合を可能にしたが,ミオシン重鎖合成と蓄積を著しく抑制した.
結論:
- ディアゼパムは,筋肉細胞の分化に直接的かつ特異的な抑制効果を発揮する.
- ミオブラスト融合は,ミオシン重鎖のような大量の筋肉固有のタンパク質の合成と蓄積と必ずしも結びつかない.
- これらの発見は,骨髄形成の調節と,特定の薬剤が筋肉の発達に与える潜在的な影響についての洞察を提供します.
関連する概念動画
Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...

